Top Markets
Coin of the day
Vicapsys Life Sciences, Inc. Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.

VICP
Clasificación en acciones #25718
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive... Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12. VYBRIN is being investigated for multiple purposes: preventing the formation of post-surgical adhesions following abdominal operations, coating implantable medical devices and other implants to inhibit fibrosis, and promoting wound healing, with a particular emphasis on diabetic ulcers. The firm, originally incorporated in 1997, transitioned its name from Phage Therapeutics International, Inc. to Vicapsys Life Sciences, Inc. in September 2017. Its operations are headquartered in Suwanee, Georgia.
Precio por acción
$1.45
Última sincronización: 2026-08-19
Capitalización bursátil
$46.94M
Cambio (1 día)
0.00%
Cambio (1 año)
-18.08%
País
US
Comercio Vicapsys Life Sciences, Inc. (VICP)

Categoría

Historial de desdoblamientos de acciones de Vicapsys Life Sciences, Inc. (VICP)
La acción Vicapsys Life Sciences, Inc. (símbolo: VICP) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 21, 2026.
Una acción VICP comprada antes de Aug 21, 2026 equivaldría hoy a 0 acciones VICP.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US